Cell type-specific immune dysregulation in severely ill COVID-19 patients is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5KL2TR001882-07
Institutional Career Development Core
National Institutes of Health
Grant: 4R01AI103542-04
Role of Blimp-1 in preventing chronic intestinal mucosal inflammation.
National Institutes of Health
Grant: 1R01HL135163-01
Epithelial progenitor cells for lung repair and regeneration
National Institutes of Health
Grant: 5R01HL137076-04
Dynactin 4 regulation of lung injury
National Institutes of Health
Grant: 5R01AI137111-02
Integrated Multi-omics of Melioidosis
National Institutes of Health
Grant: 5R01AI127406-03
Generating protective immunity to Staphylococcus aureus
National Institutes of Health
Grant: 5T32HL134637-02
Multidisciplinary Pulmonary Research Training Program
National Institutes of Health
Grant: 1R21AI151987-01
Investigating the requirement of the commensal microbiota for long term T cell immunity
National Institutes of Health
Grant: 5R01AI134987-04
Monocyte Production by Bone Marrow Progenitors
National Institutes of Health
Grant: 5P01HL108793-10
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
Fields of Study
Keywords
Sustainable Development Goals